64625-53-2

19(R)-HYDROXY PROSTAGLANDIN F2ALPHA

3-Quinolinecarbonitrile,6-amino-4-[(3-chloro-4-fluorophenyl)amino]-7-methoxy-

4-Isoxazolecarboxamide,5-amino-N-(2,3-dihydro-1H-inden-5-yl)-3-(4-pyridinyl)-

3-Pyrrolidinecarboxylic acid, 1-(4-chloro-2-methylphenyl)-5-oxo-,(tetrahydro-2-furanyl)methyl ester

Ethene, 1-(ethylsulfonyl)-2-(methylsulfonyl)-, (Z)-

1,2,4-Benzotriazine-3-acetic acid, 7-chloro-6-(trifluoromethyl)-, ethylester

3-Quinolinecarboxamide, 4-hydroxy-N-2-thiazolyl-

N-(tert-butoxycarbonyl)-l-leucine

4-Isoxazolecarboxylic acid,3-[(1S)-1-[[(1,1-dimethylethoxy)carbonyl]amino]-3-methylbutyl]-5-methyl-, 1,1-dimethylethyl ester

1,2,4-Benzotriazine-3-acetamide, 7-chloro-

3-Pyrrolidinecarboxylic acid, 1-(3,5-dimethoxyphenyl)-5-oxo-

RUTILE (GRANULAR)

3-Quinolinecarbonitrile,4-(1,3-benzodioxol-4-ylamino)-7-(2-hydroxyethoxy)-6-methoxy-,monohydrochloride

2-(4-fluorophenyl)-1-methyl-1H-indole

3-Quinolinecarboxaldehyde, 4-chloro-2-(2-hydroxyethenyl)-7-methyl-

3-Quinolinecarbonitrile, 6-formyl-4-[(1-methylethyl)thio]-

Magnesium, iodo(2-methoxyphenyl)-

1,2,4-Benzotriazine-3-acetic acid, 7-(4-methoxyphenyl)-, ethyl ester

3-Pyrrolidinecarboxylic acid, 1-(3-chloro-2-methoxyphenyl)-5-oxo-,2-methoxyethyl ester

4-Isoxazolecarboxylic acid, 5-(cyclopropylmethoxy)-3-methyl-, ethylester

3-Quinolinecarbonitrile, 6-amino-4-[(3-bromophenyl)amino]-8-methoxy-

3-Quinolinecarbonitrile,4-(1,3-benzodioxol-4-ylamino)-7-[3-(4-hydroxy-1-piperidinyl)propoxy]-6-methoxy-

3-Quinolinecarbonitrile, 7-bromo-4-(2,4-dichlorophenoxy)-

2-[(2-chloro-6-methylphenyl)amino]-N,N-dimethyl-2-oxo-N-[2-oxo-2-(phenylamino)ethyl]ethanaminium chloride

3-Quinolinecarbonitrile,4-[(2,3-dihydro-1,4-benzodioxin-5-yl)amino]-6,7-dimethoxy-

3-Quinolinecarboxaldehyde, 2-(1-piperidinyl)-

3-Pyrrolidinecarboxylic acid, 1-(2-hydroxy-2-phenylethyl)-5-oxo-

Quinoline, 3,4-diethyl-6-methoxy-2-(trifluoromethyl)-

3-Quinolinecarbothioamide,N-[(4-chlorophenyl)methyl]-1,4-dihydro-6-(3-hydroxy-1-propynyl)-1-methyl-4-oxo-

3-Quinolinecarbonitrile,1,4-dihydro-4-oxo-6-phenoxy-2-[(phenylmethyl)thio]-

3-Pyrazolidinone, 5,5-dimethyl-1-(phenylmethyl)-

3-Quinolinecarboxamide, 1,4-dihydro-4-oxo-N-3-pyridinyl-

3-Pyrrolidinecarboxylic acid, 1-(3-chloro-2-methylphenyl)-5-oxo-, methylester

2,6-TRICHLOROPHENYL ISOCYANATE

3-Quinolinecarbonitrile,7-bromo-4-[(2,4-dichloro-5-ethoxyphenyl)amino]-

3-Quinolinecarbonitrile,4-(1,3-benzodioxol-4-ylamino)-7-[(2R)-2-hydroxy-3-methoxypropoxy]-6-methoxy-

3-Quinolinecarbonitrile,4-(1,3-benzodioxol-4-ylamino)-7-[3-[(2R,5R)-2,5-dihydro-2,5-dimethyl-1H-pyrrol-1-yl]propoxy]-6-methoxy-, rel-

64625-53-2 msds

CAS No 64625-53-2 supplier

CASNo 64625-53-2 distributor

CAS # 64625-53-2 manufacturer

CAS Number 64625-53-2 safety

CAS RN 64625-53-2 wholesale

2026-10-12 19(R)-HYDROXY PROSTAGLANDIN F2ALPHA,CAS No.64625-53-2,Formula:C20H34O6. Find Related Products for Bulk Production or Scientific Research